Tralokinumab for Atopic Dermatitis: A Promising New Therapy Tralokinumab for Atopic Dermatitis: A Promising New Therapy

Multiple trials of tralokinumab, an interleukin-13 inhibitor, indicate that it is a promising treatment option for patients with moderate-to-severe atopic dermatitis.The British Journal of Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news